GlassScriptPhysician profile
Anne O Neill
NPI 1114181484
$1,821.25
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,389 · 2020: $316 · 2021: $73.74 · 2022: $42.29.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $827.59 | 2019 | |
| Ethicon US, LLC | $476.85 | 2019-2020 | |
| Mentor Worldwide LLC | $154.56 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $60.21 | 2021-2022 | |
| Merit Medical Systems INC | $59.51 | 2020 | |
| Allergan, INC. | $48.23 | 2019 | |
| Tela Bio, INC. | $41.59 | 2020 | |
| Medtronic USA, INC. | $39.28 | 2019-2020 | |
| Boston Scientific Corporation | $37.84 | 2020 | |
| Bard Peripheral Vascular, INC. | $36.13 | 2021-2022 | |
| Kci USA, INC. | $19.77 | 2020 | |
| Cardiovascular Systems INC. | $19.69 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne O Neill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.